Nov
2026
IICC, Yashobhoomi, Dwarka, Delhi
Visit us
stand 2B04

Virchow Group

Exhibitor at CPHI India 2026
About Us

Virchow Group, India, manufactures APIs, Biopharmaceuticals and Finished Dosage Forms.  APIs: Sulfamethoxazole, Sulfasalazine, Sulfadiazine, Trimethoprim, Telmisartan, Ranitidine, Tramadol, Sildenafil, Pregabalin, Levetiracetam, Cephalosporins.  Intermediates: 7-AVCA, GCLE, Cis-Lactam. Biotech FDFs: Recombinant Biosimilars (PDGF, PTH, PEG Interferon, Rasburicase), Blood Products (Albumin, IVIG), Probiotics, HA PFS, Cardio, Gastro, Oncology products, Surgical & Wound care products and PFS, BFS, PEN cartridge injectables.  Group companies hold USFDA, EU, KFDA cGMPs. 

Read more Show less
Products
Show more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    India
  • On CPHI since:
    2015
  • Certificates:
    2
  • Employees:
    5000+
Company types
Manufacturer/Innovator
Primary activities
API Producer
Biopharmaceutical
Nutraceuticals
Pharmaceutical Company (generic finished products)
View company profile
Contact info
  • ++91 40 4444 5678
  • Plot No. 4 to 10, S.V. Co-op. Indl. Estate,, I.D.A.,, Jeedimetla, 500 055, Hyderabad, India
Show contact info Hide contact info
Event information
CPHI India 2026
  • 23 Nov 2026 - 25 Nov 2026
  • IICC, Yashobhoomi, Dwarka, Delhi
  • Visit us at stand 2B04

Products Featured at CPHI India 2026

Virchow Group Resources (1)